Most private insurers dont cover GLP-1s for weight loss, which can make the drugs unaffordable for those paying out of pocket
La semaglutida, en particular, se ha asociado con empeoramiento temporal de la retinopata diabtica en algunos pacientes
Ideal candidates understand that oral semaglutide is not a cosmetic or temporary solution but a tool for managing a chronic metabolic condition
Semaglutide treatment resulted in a 24% reduction in major kidney disease, a composite of kidney failure, at least a 50% reduction in estimated glomerular filtration rate from baseline or death from kidney-associated or cardiovascular causes
Trial Registration Trial registration: clinicalTrial.gov NCT04113889
Regulate Your Appetite Semaglutide mimics the natural hormones that regulate your appetite, helping you feel full for longer and manage cravings